High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease.
We report the largest genetic association study of blood pressure traits (systolic, diastolic …

Background Globally, access to healthcare and diagnostic technologies are known to
substantially impact the reported birth prevalence of congenital heart disease (CHD). Previous …

Genome-wide association studies (GWAS) in coronary artery disease (CAD) had identified
66 loci at'genome-wide significance'(P< 5× 10− 8) at the time of this analysis, but a much …

Background Variants of certain haemostatic genes (such as that encoding factor V Leiden)
are involved in the development of venous thrombosis, but studies of such variants in …

Previous studies have shown that copy-number variants (CNVs) contribute to the risk of
complex developmental phenotypes. However, the contribution of global CNV burden to the risk …

Background Although there have been suggestions that serum paraoxonase is important in
protecting against coronary heart disease (CHD), a large number of studies of genetic …

Background Bariatric surgery has been shown to improve cardiovascular risk factors but
long term benefits for survival and cardiovascular events are still uncertain. Methods We …

Objective To quantify any risk of atrial fibrillation (AF) associated with ivabradine treatment
by meta-analysis of clinical trial data. Methods Medline, Embase, Web of Knowledge and the …

Congenital cardiovascular malformation (CVM) exhibits familial predisposition, but most of
the specific genetic factors involved are unknown. Postulating that rare variants in genes in …

We carried out a genome-wide association study (GWAS) of congenital heart disease (CHD).
Our discovery cohort comprised 1,995 CHD cases and 5,159 controls and included …